Free Newsletter
Seroquel user wants FDA to see sealed papers
A patient who claims the psychiatric drug Seroquel gave him diabetes has asked a judge to unseal AstraZeneca's confidential documents about its side effects--before the FDA decides whether to grant a new indication covering millions of patients with depression and/or anxiety. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





